DNA methyltransferase antisense oligonucleotides
US5578716A · kind A · utility
63Cited by
0References
4Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Dec 1, 1993 |
| Grant date | Nov 26, 1996 |
| Priority date | — |
| Expiry date | Dec 1, 2013 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2310/315
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The invention encompasses tumorigenicity-inhibiting antisense oligonucleotide sequences complementary to mRNA or double-stranded DNA that encodes mammalian DNA methyl transferase. It further encompasses methods for inhibiting tumorigenicity and pharmaceutical composition comprises the tumorigenicity-inhibiting antisense nucleotide.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.